另一种形式的伤害预防:创伤人群中成功开展HIV和丙型肝炎筛查与转诊
本研究在一家学术一级创伤中心将HIV和HCV筛查加入创伤激活实验室常规医嘱,2016年1月1日至2017年6月30日前瞻性收集数据。共1898例创伤激活患者,1217例(64.1%)完成筛查,7%初筛阳性,5.5%确认阳性,HIV和HCV感染率均接近全国平均的三倍,新诊断率3.3%。超过85%的病例转诊随访,但结合诊疗率仅43.3%。作者认为应考虑对创伤患者进行常规筛查以提高诊断率和结合诊疗率。
要点
- 在学术一级创伤中心,将HIV和HCV筛查加入创伤激活实验室常规医嘱后,64.1%(1217/1898)的创伤激活患者完成筛查。
- 筛查人群中7%初筛阳性,5.5%确认阳性;HIV感染率1.1%,HCV感染率4.4%,均接近全国平均的三倍。
- 总体新诊断率3.3%;HCV新诊断率3%,为全国平均的两倍。
- 超过85%的病例转诊随访,但合并结合诊疗率仅43.3%。
- 作者认为应考虑对创伤患者进行常规筛查,以提高诊断率、结合诊疗率并减少疾病传播。
适用人群与场景
- 学术一级创伤中心的创伤激活患者,数据收集自2016年1月1日至2017年6月30日。
处置流程与药物剂量
- 将HCV和HIV筛查试验加入创伤激活实验室常规医嘱,当有指征时送确认性病毒载量检测。
- 对阳性结果患者进行疾病教育并转诊至疾病特异性随访。
研究设计与关键结果
- 研究类型为前瞻性质量改进项目,样本量1898例创伤激活患者,单中心学术一级创伤中心。
- 1217例(64.1%)完成筛查,其中Level A患者筛查率75.6%,Level B患者筛查率60.2%。
- 筛查患者中7%初筛阳性,5.5%确认阳性;HIV感染率1.1%,HCV感染率4.4%,均接近全国平均的三倍。
- 总体新诊断率3.3%;HCV新诊断率3%,为全国平均的两倍。
- 超过85%的病例转诊随访,合并结合诊疗率43.3%。
证据类型、等级与局限
- 证据类型:前瞻性质量改进项目;证据等级:治疗/管理,level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为应考虑对创伤患者进行常规筛查,以提高诊断率、结合诊疗率并减少疾病传播。
- 作者认为这些筛查努力有助于弥合创伤人群中因保险率较低和初级保健可及性有限而存在的医疗保健差距。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In the United States, millions of patients are living with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (0.44% and 1.5%) and many are currently undiagnosed. Because highly effective treatments are now available, early identification of these patients is extremely important to achieve improved clinical outcomes. Prior data and trauma-associated risk factors suggest a higher prevalence of both diseases in the trauma population. We hypothesized that a screening program could be successfully initiated among trauma activation patients and that a referral and linkage-to-care program could be developed.
METHODS: Hepatitis C virus and HIV screening tests were added to standard trauma activation laboratory orders at an academic Level I Trauma Center. Confirmatory viral load was sent when indicated. Patients with positive results were educated about their disease and referred to disease-specific follow-up. Data were collected prospectively from January 1, 2016, until June 30, 2017. Total and new diagnosis, referral rates, and linkage-to-care rates were analyzed.
RESULTS: One thousand eight hundred ninety-eight patients arrived as trauma activations. One thousand two hundred seventeen (64.1%) patients were screened (Level A, 75.6%; Level B, 60.2%). Seven percent of the screened patients were initially positive, and 5.5% were confirmed positive. Rates of both HIV (1.1%) and HCV (4.4%) were almost triple the national average. Overall, 3.3% screened positive for a new diagnosis. For HCV, the rate of new diagnosis was twice the national average (3%). Over 85% of all cases were referred for follow-up, and the combined linkage-to-care rate was 43.3%.
CONCLUSION: The majority of patients were screened and referred for follow-up, indicating successful implementation of our trauma screening program. Routine screening of trauma patients should be considered to increase diagnosis rate, increase linkage-to-care rates, and decrease disease transmission. These screening efforts would help bridge the health care gap that exists in the trauma population due to lower insurance rates and limited access to primary care.
LEVEL OF EVIDENCE: Therapeutic/Care management, level III.
参考来源
- Privette AR, White B, Ferguson PL, et al. A different form of injury prevention: Successful screening and referral for human immunodeficiency virus and hepatitis C virus in a trauma population. J Trauma Acute Care Surg. 2018. PMID: 30358756. doi:10.1097/TA.0000000000001991
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。